Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
177M
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
18.7M
-
Shares change
-
-532K
-
Total reported value, excl. options
-
$74.3M
-
Value change
-
-$5.8M
-
Put/Call ratio
-
0.78
-
Number of buys
-
30
-
Number of sells
-
-28
-
Price
-
$3.98
Significant Holders of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) as of Q4 2018
79 filings reported holding OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share as of Q4 2018.
OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.7M shares
of 177M outstanding shares and own 10.55% of the company stock.
Largest 10 shareholders include SUMMER ROAD LLC (3.78M shares), Versant Venture Management, LLC (2.22M shares), FMR LLC (2.03M shares), JENNISON ASSOCIATES LLC (1.63M shares), Vanguard Group Inc (1.59M shares), Man Group plc (1.19M shares), WELLINGTON MANAGEMENT GROUP LLP (1.15M shares), DELTEC ASSET MANAGEMENT LLC (725K shares), SV Health Investors, LLC (628K shares), and STATE STREET CORP (485K shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.